In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling

Karen A. Nolan, Mark S. Dunstan, Mary C. Caraher, Katherine A. Scott, David Leys, Ian J. Stratford

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology

    Pharmacology, Toxicology and Pharmaceutical Science